[Federal Register Volume 64, Number 165 (Thursday, August 26, 1999)]
[Notices]
[Pages 46696-46697]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-22237]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Call for Nominations for the National
Cancer Institute Director's Consumer Liaison Group
The National Cancer Institute (NCI), the Federal Government's
primary agency for cancer research, is now accepting nominations for
five members of the National Cancer Institute Director's Consumer
Liaison Group (DCLG) who will be appointed in July, 2000. The DCLG is a
chartered Federal advisory committee of the NCI. It consists of 15
consumer advocates who are involved in cancer advocacy and who reflect
the diversity among those whose lives are affected by cancer. DCLG
members are appointed for three-year terms.
NCI brings together these advocates from many communities to advise
and make recommendations to the Director, NCI, from the consumer
advocate perspective on a wide variety of issues, programs and research
priorities. The DCLG serves as a channel for consumer advocates to
voice their views and concerns. Specifically the DCLG members:
Help develop and establish processes, mechanisms, and
criteria for identifying appropriate consumer advocates to serve on a
variety of program and policy advisory committees responsible for
advancing the mission of the NCI.
Serve as a primary forum for discussing issues and
concerns and exchanging viewpoints that are important to the broad
development of the NCI programmatic and research priorities.
Establish and maintain strong collaborations between the
NCI and the
[[Page 46697]]
cancer advocacy community to reach common goals.
Eligibility Requirements for Individual Members
To serve on the DCLG, a member must meet the following minimum
eligibility requirements:
Be involved in the cancer experience as a cancer survivor,
a person affected by the suffering and consequences of cancer, or a
professional or volunteer who works with survivors or those affected.
Represent a constituency (formally or informally) with
whom she or he communicates regularly on cancer issues and be able to
serve as a conduit for information both to and from his/her
constituency.
DCLG members must be committed to participating in all activities
of the DCLG which includes at least two meetings a year in Bethesda.
Criteria for Evaluating Individual Candidates
Nominees who meet the minimum eligibility requirements will be
further assessed based on the following criteria:
Cancer advocacy experience.
Ability to communicate effectively.
Ability to represent broad issues, think ``globally''.
Ability to contribute to an effective group process.
Leadership ability.
Characteristics of the DCLG
In addition to the criteria for individual candidates, the
following characteristics of the DCLG as a group are intended to ensure
that it reflects the breadth and diversity of the consumer advocacy
community:
Multicultural diversity.
A broad mix of cancer sites.
Representation of the medically underserved.
Men and women.
A range of organizations (local/regional and national).
Age diversity.
Geographic diversity (rural/urban mix).
Selection Process
A call for nominations is disseminated annually to a broad range of
groups, including local, regional and national organizations, to
encourage nominations of candidates reflecting the diversity sought for
the DCLG. All nominees are screened for eligibility, then evaluated
according to the criteria. A list of highly qualified candidates who
reflect balance and diversity of representation is forwarded to the
Director, NCI, who selects the DCLG members. The original members of
the DCLG endorsed this process, which will be used to select future
members.
Nominations may come from members of organizations, or individuals,
including self-nominations. The nominations must be postmarked no later
than November 1, 1999. To request a nomination package send your name,
advocacy organization affiliation (if any), and address to the Office
of Liaison Activities, NCI, Building 31; Room 10A06, 31 Center Drive,
MSC 2580, Bethesda, MD 20892-2580. You may also request a package via
fax to 301 480-7558 or e-mail to [email protected]
Dated: August 19, 1999.
LaVerne Stringfield,
Director, Office of Federal Advisory Committee Policy, National
Institutes of Health.
[FR Doc. 99-22237 Filed 8-25-99; 8:45 am]
BILLING CODE 4140-01-M